<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(1)</volume><submitter>Sun H</submitter><pubmed_abstract>Changes in structure of oral solid dosage forms (OSDF) elementally determine the drug release and its therapeutic effects. In this research, synchrotron radiation X-ray micro-computed tomography was utilized to visualize the 3D structure of enteric coated pellets recovered from the gastrointestinal tract of rats. The structures of pellets in solid state and &lt;i>in vitro&lt;/i> compendium media were measured. Pellets &lt;i>in vivo&lt;/i> underwent morphological and structural changes which differed significantly from those &lt;i>in vitro&lt;/i> compendium media. Thus, optimizations of the dissolution media were performed to mimic the appropriate &lt;i>in vivo&lt;/i> conditions by introducing pepsin and glass microspheres in media. The sphericity, pellet volume, pore volume and porosity of the &lt;i>in vivo&lt;/i> esomeprazole magnesium pellets in stomach for 2 h were recorded 0.47, 1.55 × 10&lt;sup>8&lt;/sup> μm&lt;sup>3&lt;/sup>, 0.44 × 10&lt;sup>8&lt;/sup> μm&lt;sup>3&lt;/sup> and 27.6%, respectively. After adding pepsin and glass microspheres, the above parameters &lt;i>in vitro&lt;/i> reached to 0.44, 1.64 × 10&lt;sup>8&lt;/sup> μm&lt;sup>3&lt;/sup>, 0.38 × 10&lt;sup>8&lt;/sup> μm&lt;sup>3&lt;/sup> and 23.0%, respectively. Omeprazole magnesium pellets behaved similarly. The structural features of pellets between &lt;i>in vitro&lt;/i> media and &lt;i>in vivo&lt;/i> condition were bridged successfully in terms of 3D structures to ensure better design, characterization and quality control of advanced OSDF.</pubmed_abstract><journal>Acta pharmaceutica Sinica. B</journal><pagination>326-338</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8799995</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Bridging the structure gap between pellets in artificial dissolution media and in gastro-intestinal tract in rats.</pubmed_title><pmcid>PMC8799995</pmcid><pubmed_authors>Yin X</pubmed_authors><pubmed_authors>Wu L</pubmed_authors><pubmed_authors>Xu M</pubmed_authors><pubmed_authors>Ning B</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Sun X</pubmed_authors><pubmed_authors>Xiao T</pubmed_authors><pubmed_authors>York P</pubmed_authors><pubmed_authors>He S</pubmed_authors><pubmed_authors>Cao Z</pubmed_authors><pubmed_authors>Lu S</pubmed_authors><pubmed_authors>Sun H</pubmed_authors><pubmed_authors>Xu X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Bridging the structure gap between pellets in artificial dissolution media and in gastro-intestinal tract in rats.</name><description>Changes in structure of oral solid dosage forms (OSDF) elementally determine the drug release and its therapeutic effects. In this research, synchrotron radiation X-ray micro-computed tomography was utilized to visualize the 3D structure of enteric coated pellets recovered from the gastrointestinal tract of rats. The structures of pellets in solid state and &lt;i>in vitro&lt;/i> compendium media were measured. Pellets &lt;i>in vivo&lt;/i> underwent morphological and structural changes which differed significantly from those &lt;i>in vitro&lt;/i> compendium media. Thus, optimizations of the dissolution media were performed to mimic the appropriate &lt;i>in vivo&lt;/i> conditions by introducing pepsin and glass microspheres in media. The sphericity, pellet volume, pore volume and porosity of the &lt;i>in vivo&lt;/i> esomeprazole magnesium pellets in stomach for 2 h were recorded 0.47, 1.55 × 10&lt;sup>8&lt;/sup> μm&lt;sup>3&lt;/sup>, 0.44 × 10&lt;sup>8&lt;/sup> μm&lt;sup>3&lt;/sup> and 27.6%, respectively. After adding pepsin and glass microspheres, the above parameters &lt;i>in vitro&lt;/i> reached to 0.44, 1.64 × 10&lt;sup>8&lt;/sup> μm&lt;sup>3&lt;/sup>, 0.38 × 10&lt;sup>8&lt;/sup> μm&lt;sup>3&lt;/sup> and 23.0%, respectively. Omeprazole magnesium pellets behaved similarly. The structural features of pellets between &lt;i>in vitro&lt;/i> media and &lt;i>in vivo&lt;/i> condition were bridged successfully in terms of 3D structures to ensure better design, characterization and quality control of advanced OSDF.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2026-03-18T13:43:13.679Z</modification><creation>2025-05-29T16:07:02.113Z</creation></dates><accession>S-EPMC8799995</accession><cross_references><pubmed>35127389</pubmed><doi>10.1016/j.apsb.2021.05.010</doi></cross_references></HashMap>